Public annual accounts

OSTEOMED CONCERN financials

Name: OSTEOMED CONCERN financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for OSTEOMED CONCERN, with comparable measures and links to available source documents.

Company overview

Registry number

0820299306

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for OSTEOMED CONCERN

2025 versus 2024

Operating line: €110,106
EBITDA: €100,977
Total assets: €991,099
Equity: €467,653

EBITDA margin +91.7% · Equity ratio +47.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€110,106	€100,977	€991,099	€467,653	-
202431 Dec 2024	€207,766	€200,239	€1,095,085	€467,940	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report